Literature DB >> 35626250

Reply to Nicholas et al. Using a ResNet-18 Network to Detect Features of Alzheimer's Disease on Functional Magnetic Resonance Imaging: A Failed Replication. Comment on "Odusami et al. Analysis of Features of Alzheimer's Disease: Detection of Early Stage from Functional Brain Changes in Magnetic Resonance Images Using a Finetuned ResNet18 Network. Diagnostics 2021, 11, 1071".

Modupe Odusami1, Rytis Maskeliūnas1, Robertas Damaševičius2, Tomas Krilavičius2.   

Abstract

We have studied the manuscript of Nicholas et al. [...].

Entities:  

Year:  2022        PMID: 35626250      PMCID: PMC9140066          DOI: 10.3390/diagnostics12051097

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


We have studied the manuscript of Nicholas et al. [1] very attentively; here are our comments: The authors have used a different dataset (ADNI-3, rather than ADNI-2 used in [2]). The protocols of ADNI-2 and ADNI-3 datasets are not fully consistent [3]. The ADNI MR data set includes a wide range of scanner platforms; however, there has been a broad gap between older MRI systems and the state-of-the-art systems within each vendor’s product line. In ADNI-3, the “ADNI 3 Basic” and “ADNI 3 Advanced” protocols were used. The authors failed to mention if the images they used were made using a protocol compatible with ADNI-2. The dMRI spatial resolution was improved between ADNI-2 and ADNI-3 by reducing the voxel size from 2.7 × 2.7 × 2.7 mm to 2.0 × 2.0 × 2.0 mm [4]. This may have influenced the results. Moreover, the classification results among these studies are not directly comparable, because they differ in terms of the sets of participants. We fully agree that the replication of important findings by multiple independent investigators is fundamental to the accumulation of scientific evidence [5]. Deep learning network models are notoriously known for being difficult to replicate, even if the same sets of parameters are used. The training of neural network models is not deterministic, so the models are likely to produce differing results [6]. The strive of the authors to precisely replicate the results may not be achievable. Considering the description of the training process described in their manuscript, we have tried our model on the ADNI-3 dataset using both cross-validation procedures used by To et al., However, we failed to replicate their results (see the result Table 1 and Figure 1).
Table 1

Replicated results.

Binary ClassesAccuracy (%)Sensitivity (%)Specificity (%)
EMCI vs. LMCI70.6268.9895.23
CN vs. EMCI77.3073.5092.03
Figure 1

Confusion matrices of replicated result.

Our result is not exceptional. In fact, it is in line with the state-of-the-art studies, which achieved a similar high performance in the ADNI dataset by using 2D CNN, ResNet-18 [7] and custom CNN [8], as well as in other datasets such as OASIS [9,10]. We are somewhat puzzled as to why the performance reported by To et al. on the ADNI dataset is so low.
  7 in total

1.  A Deep Learning Approach for Automated Diagnosis and Multi-Class Classification of Alzheimer's Disease Stages Using Resting-State fMRI and Residual Neural Networks.

Authors:  Farheen Ramzan; Muhammad Usman Ghani Khan; Asim Rehmat; Sajid Iqbal; Tanzila Saba; Amjad Rehman; Zahid Mehmood
Journal:  J Med Syst       Date:  2019-12-18       Impact factor: 4.460

2.  Using a ResNet-18 Network to Detect Features of Alzheimer's Disease on Functional Magnetic Resonance Imaging: A Failed Replication. Comment on Odusami et al. Analysis of Features of Alzheimer's Disease: Detection of Early Stage from Functional Brain Changes in Magnetic Resonance Images Using a Finetuned ResNet18 Network. Diagnostics 2021, 11, 1071.

Authors:  Peter J Nicholas; Alex To; Onur Tanglay; Isabella M Young; Michael E Sughrue; Stéphane Doyen
Journal:  Diagnostics (Basel)       Date:  2022-04-27

3.  Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3.

Authors:  Artemis Zavaliangos-Petropulu; Talia M Nir; Sophia I Thomopoulos; Robert I Reid; Matt A Bernstein; Bret Borowski; Clifford R Jack; Michael W Weiner; Neda Jahanshad; Paul M Thompson
Journal:  Front Neuroinform       Date:  2019-02-19       Impact factor: 4.081

4.  Automated classification of Alzheimer's disease and mild cognitive impairment using a single MRI and deep neural networks.

Authors:  Silvia Basaia; Federica Agosta; Luca Wagner; Elisa Canu; Giuseppe Magnani; Roberto Santangelo; Massimo Filippi
Journal:  Neuroimage Clin       Date:  2018-12-18       Impact factor: 4.881

5.  Classification of Alzheimer's Disease with and without Imagery using Gradient Boosted Machines and ResNet-50.

Authors:  Lawrence V Fulton; Diane Dolezel; Jordan Harrop; Yan Yan; Christopher P Fulton
Journal:  Brain Sci       Date:  2019-08-22

6.  Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation.

Authors:  Junhao Wen; Elina Thibeau-Sutre; Mauricio Diaz-Melo; Jorge Samper-González; Alexandre Routier; Simona Bottani; Didier Dormont; Stanley Durrleman; Ninon Burgos; Olivier Colliot
Journal:  Med Image Anal       Date:  2020-05-01       Impact factor: 8.545

7.  Analysis of Features of Alzheimer's Disease: Detection of Early Stage from Functional Brain Changes in Magnetic Resonance Images Using a Finetuned ResNet18 Network.

Authors:  Modupe Odusami; Rytis Maskeliūnas; Robertas Damaševičius; Tomas Krilavičius
Journal:  Diagnostics (Basel)       Date:  2021-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.